LeMaitre Vascular, Inc.
LMAT
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion cathetersā¦ read more
Healthcare
Medical Instruments & Supplies
19 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$109.17
Price+2.15%
$2.30
1Y
Price
Market Cap
$2.487b
Mid
Price/Earnings 3y Avg5y Avg
43.3x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+37.6%
EBITDA Margin+24.2%
Net Profit Margin+33.2%
Free Cash Flow Margin+37.6%
EBITDA Margin+24.2%
Net Profit Margin+33.2%
Free Cash Flow MarginRevenue
$249.602m
+13.5%
1y CAGR+15.6%
3y CAGR+12.9%
5y CAGREarnings
$57.734m
+31.1%
1y CAGR+41.1%
3y CAGR+25.0%
5y CAGREPS
$2.52
+30.0%
1y CAGR+39.4%
3y CAGR+23.1%
5y CAGRBook Value
$393.516m
$615.690m
Assets$222.174m
Liabilities$185.592m
DebtDebt to Assets
30.1%
2x
Debt to EBITDAFree Cash Flow
$74.468m
+100.4%
1y CAGR+53.2%
3y CAGR+33.2%
5y CAGRNo items found.
Press Releases
Statements and updates from the company